221 related articles for article (PubMed ID: 25270115)
1. Intra-arterial delivery of AAV vectors to the mouse brain after mannitol mediated blood brain barrier disruption.
Foley CP; Rubin DG; Santillan A; Sondhi D; Dyke JP; Crystal RG; Gobin YP; Ballon DJ
J Control Release; 2014 Dec; 196():71-78. PubMed ID: 25270115
[TBL] [Abstract][Full Text] [Related]
2. Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits.
Wang M; Etu J; Joshi S
J Neurosurg Anesthesiol; 2007 Oct; 19(4):249-56. PubMed ID: 17893577
[TBL] [Abstract][Full Text] [Related]
3. Hyperosmolar blood-brain barrier opening using intra-arterial injection of hyperosmotic mannitol in mice under real-time MRI guidance.
Chu C; Jablonska A; Gao Y; Lan X; Lesniak WG; Liang Y; Liu G; Li S; Magnus T; Pearl M; Janowski M; Walczak P
Nat Protoc; 2022 Jan; 17(1):76-94. PubMed ID: 34903870
[TBL] [Abstract][Full Text] [Related]
4. Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector.
Sondhi D; Hackett NR; Peterson DA; Stratton J; Baad M; Travis KM; Wilson JM; Crystal RG
Mol Ther; 2007 Mar; 15(3):481-91. PubMed ID: 17180118
[TBL] [Abstract][Full Text] [Related]
5. Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.
Crystal RG; Sondhi D; Hackett NR; Kaminsky SM; Worgall S; Stieg P; Souweidane M; Hosain S; Heier L; Ballon D; Dinner M; Wisniewski K; Kaplitt M; Greenwald BM; Howell JD; Strybing K; Dyke J; Voss H
Hum Gene Ther; 2004 Nov; 15(11):1131-54. PubMed ID: 15610613
[TBL] [Abstract][Full Text] [Related]
6. Deuterium oxide as a contrast medium for real-time MRI-guided endovascular neurointervention.
Chen L; Liu J; Chu C; Han Z; Yadav N; Xu J; Bai R; Staedtke V; Pearl M; Walczak P; van Zijl P; Janowski M; Liu G
Theranostics; 2021; 11(13):6240-6250. PubMed ID: 33995656
[No Abstract] [Full Text] [Related]
7. The effects of pentobarbital on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Chun TW; Liu X; Weiss HR
Anesth Analg; 1998 Jun; 86(6):1230-5. PubMed ID: 9620510
[TBL] [Abstract][Full Text] [Related]
8. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain.
Fu H; Muenzer J; Samulski RJ; Breese G; Sifford J; Zeng X; McCarty DM
Mol Ther; 2003 Dec; 8(6):911-7. PubMed ID: 14664793
[TBL] [Abstract][Full Text] [Related]
9. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM
J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648
[TBL] [Abstract][Full Text] [Related]
10. Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis.
Sondhi D; Johnson L; Purpura K; Monette S; Souweidane MM; Kaplitt MG; Kosofsky B; Yohay K; Ballon D; Dyke J; Kaminksy SM; Hackett NR; Crystal RG
Hum Gene Ther Methods; 2012 Oct; 23(5):324-35. PubMed ID: 23131032
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and Safety of Intra-arterial Pericyte Progenitor Cell Delivery Following Mannitol-Induced Transient Blood-Brain Barrier Opening in a Canine Model.
Youn SW; Jung KH; Chu K; Lee JY; Lee ST; Bahn JJ; Park DK; Yu JS; Kim SY; Kim M; Lee SK; Han MH; Roh JK
Cell Transplant; 2015; 24(8):1469-79. PubMed ID: 24932854
[TBL] [Abstract][Full Text] [Related]
12. Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82.
Zünkeler B; Carson RE; Olson J; Blasberg RG; Girton M; Bacher J; Herscovitch P; Oldfield EH
J Neurosurg; 1996 Mar; 84(3):494-502. PubMed ID: 8609564
[TBL] [Abstract][Full Text] [Related]
13. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.
Yang W; Barth RF; Carpenter DE; Moeschberger ML; Goodman JH
Neurosurgery; 1996 May; 38(5):985-92. PubMed ID: 8727825
[TBL] [Abstract][Full Text] [Related]
14. Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy.
Joshi S; Ergin A; Wang M; Reif R; Zhang J; Bruce JN; Bigio IJ
J Neurooncol; 2011 Aug; 104(1):11-9. PubMed ID: 21153681
[TBL] [Abstract][Full Text] [Related]
15. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption.
Doran SE; Ren XD; Betz AL; Pagel MA; Neuwelt EA; Roessler BJ; Davidson BL
Neurosurgery; 1995 May; 36(5):965-70. PubMed ID: 7791989
[TBL] [Abstract][Full Text] [Related]
16. The effects of the Na(+)/Ca(++) exchange blocker on osmotic blood-brain barrier disruption.
Bhattacharjee AK; Nagashima T; Kondoh T; Tamaki N
Brain Res; 2001 May; 900(2):157-62. PubMed ID: 11334793
[TBL] [Abstract][Full Text] [Related]
17. A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery.
Muldoon LL; Pagel MA; Kroll RA; Roman-Goldstein S; Jones RS; Neuwelt EA
AJNR Am J Neuroradiol; 1999 Feb; 20(2):217-22. PubMed ID: 10094341
[TBL] [Abstract][Full Text] [Related]
18. Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going.
D'Amico RS; Khatri D; Reichman N; Patel NV; Wong T; Fralin SR; Li M; Ellis JA; Ortiz R; Langer DJ; Boockvar JA
J Neurooncol; 2020 Apr; 147(2):261-278. PubMed ID: 32076934
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
20. Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice.
McCarty DM; DiRosario J; Gulaid K; Muenzer J; Fu H
Gene Ther; 2009 Nov; 16(11):1340-52. PubMed ID: 19587708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
